PT  - JOURNAL ARTICLE
AU  - Parry, Nicola
ED  - Buyse, Gunnar
TI  - Idebenone Delays Respiratory Decline in Duchenne Muscular Dystrophy
DP  - 2015 Jun 20
TA  - MD Conference Express
PG  - 6--7
VI  - 15
IP  - 9
4099  - http://mdc.sagepub.com/content/15/9/6.short
4100  - http://mdc.sagepub.com/content/15/9/6.full
AB  - The randomized phase 3 DELOS trial was designed to evaluate idebenone, a synthetic quinone compound, in Duchenne muscular dystrophy. The data showed that idebenone was safe and well tolerated, and it significantly reduced loss of respiratory function in patients aged 10 to 18 years.